In general, tumours that neither express oestrogen receptor (ER), progesterone receptor (PR), nor human epidermal growth factor receptor 2 (HER2) are defined as triple-negative breast cancer (TNBC) [29]. This evidence concerns the gene PGR and triple-negative breast carcinoma.